AJ MartÃ-CarvajalPI MartÃ-Carvajal2026-03-222026-03-22200410.1002/14651858.cd004887https://doi.org/10.1002/14651858.cd004887https://andeanlibrary.org/handle/123456789/87113This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of human recombinant factor VIIa for patients with liver disease and upper gastrointestinal bleeding.enUpper gastrointestinal bleedingRecombinant DNAMedicineGastrointestinal bleedingGastroenterologyLiver diseaseIntervention (counseling)Factor VIIaInternal medicineHuman recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseasesreference-entry